US Stock MarketDetailed Quotes

MRSN Mersana Therapeutics

Watchlist
  • 0.643
  • +0.123+23.62%
Close Jan 24 16:00 ET
  • 0.612
  • -0.031-4.87%
Pre 07:00 ET
79.47MMarket Cap-1.07P/E (TTM)

Mersana Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
63.65%12.6M
-78.48%2.29M
18.50%9.25M
38.65%36.86M
-27.14%10.7M
38.13%7.7M
148.69%10.65M
283.20%7.8M
61,716.28%26.58M
133,427.27%14.69M
Operating revenue
63.65%12.6M
-78.48%2.29M
18.50%9.25M
38.65%36.86M
-27.14%10.7M
38.13%7.7M
148.69%10.65M
283.20%7.8M
61,716.28%26.58M
133,427.27%14.69M
Cost of revenue
Gross profit
Operating expense
-43.20%24.67M
-58.68%27.75M
-53.90%30.25M
-9.78%207.81M
-47.73%31.63M
-33.41%43.43M
19.85%67.16M
35.02%65.6M
36.38%230.35M
25.96%60.51M
Selling and administrative expenses
-23.50%9.86M
-42.25%10.5M
-36.93%11.56M
4.53%59.54M
-31.55%10.13M
-11.52%12.89M
22.86%18.19M
43.39%18.33M
54.42%56.96M
38.70%14.81M
-General and administrative expense
-23.50%9.86M
-42.25%10.5M
-36.93%11.56M
4.53%59.54M
-31.55%10.13M
-11.52%12.89M
22.86%18.19M
43.39%18.33M
54.42%56.96M
38.70%14.81M
Research and development costs
-51.51%14.8M
-64.78%17.25M
-60.47%18.69M
-14.49%148.27M
-52.97%21.5M
-39.71%30.53M
18.77%48.97M
32.03%47.28M
31.34%173.39M
22.32%45.71M
Operating profit
66.22%-12.07M
54.95%-25.46M
63.67%-21M
16.10%-170.96M
54.33%-20.93M
40.09%-35.73M
-9.18%-56.5M
-24.16%-57.8M
-20.67%-203.77M
4.59%-45.83M
Net non-operating interest income expense
-56.85%986K
-45.90%1.19M
3.48%1.7M
1,897.75%8M
108.76%1.88M
1,428.49%2.29M
567.80%2.19M
332.01%1.64M
62.98%-445K
194.75%902K
Non-operating interest income
-40.28%1.97M
-32.59%2.17M
2.90%2.7M
318.77%12.07M
57.07%2.93M
366.38%3.3M
1,006.19%3.22M
14,461.11%2.62M
4,335.38%2.88M
6,334.48%1.87M
Non-operating interest expense
-3.05%986K
-4.10%983K
1.93%1M
22.39%4.07M
8.71%1.05M
15.57%1.02M
34.87%1.03M
35.77%983K
162.67%3.33M
-1.73%964K
Other net income (expense)
-8.71M
-499K
-8.21M
Special income (charges)
--0
----
----
---8.71M
---499K
---8.21M
----
----
--0
--0
-Less:Restructuring and merger&acquisition
--0
----
----
--8.71M
--499K
--8.21M
----
----
--0
--0
Income before tax
73.39%-11.08M
55.31%-24.27M
65.63%-19.31M
15.94%-171.67M
56.50%-19.54M
30.35%-41.66M
-4.00%-54.31M
-18.84%-56.16M
-20.08%-204.21M
8.29%-44.92M
Income tax
418K
0
Net income
72.39%-11.5M
55.31%-24.27M
65.63%-19.31M
15.94%-171.67M
56.50%-19.54M
30.35%-41.66M
-4.00%-54.31M
-18.84%-56.16M
-20.08%-204.21M
8.29%-44.92M
Net income continuous Operations
72.39%-11.5M
55.31%-24.27M
65.63%-19.31M
15.94%-171.67M
56.50%-19.54M
30.35%-41.66M
-4.00%-54.31M
-18.84%-56.16M
-20.08%-204.21M
8.29%-44.92M
Minority interest income
Net income attributable to the parent company
72.39%-11.5M
55.31%-24.27M
65.63%-19.31M
15.94%-171.67M
56.50%-19.54M
30.35%-41.66M
-4.00%-54.31M
-18.84%-56.16M
-20.08%-204.21M
8.29%-44.92M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
72.39%-11.5M
55.31%-24.27M
65.63%-19.31M
15.94%-171.67M
56.50%-19.54M
30.35%-41.66M
-4.00%-54.31M
-18.84%-56.16M
-20.08%-204.21M
8.29%-44.92M
Basic earnings per share
74.29%-0.09
57.45%-0.2
69.23%-0.16
32.11%-1.48
63.64%-0.16
42.62%-0.35
14.55%-0.47
11.86%-0.52
9.54%-2.18
35.29%-0.44
Diluted earnings per share
74.29%-0.09
57.45%-0.2
69.23%-0.16
32.11%-1.48
63.64%-0.16
42.62%-0.35
14.55%-0.47
11.86%-0.52
9.54%-2.18
35.29%-0.44
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024 (Q2)Jun 30, 2024 (Q1)Mar 31, 2024 (FY)Dec 31, 2023 (Q4)Dec 31, 2023 (Q3)Sep 30, 2023 (Q2)Jun 30, 2023 (Q1)Mar 31, 2023 (FY)Dec 31, 2022 (Q4)Dec 31, 2022
Total revenue 63.65%12.6M -78.48%2.29M 18.50%9.25M 38.65%36.86M -27.14%10.7M 38.13%7.7M 148.69%10.65M 283.20%7.8M 61,716.28%26.58M 133,427.27%14.69M
Operating revenue 63.65%12.6M -78.48%2.29M 18.50%9.25M 38.65%36.86M -27.14%10.7M 38.13%7.7M 148.69%10.65M 283.20%7.8M 61,716.28%26.58M 133,427.27%14.69M
Cost of revenue
Gross profit
Operating expense -43.20%24.67M -58.68%27.75M -53.90%30.25M -9.78%207.81M -47.73%31.63M -33.41%43.43M 19.85%67.16M 35.02%65.6M 36.38%230.35M 25.96%60.51M
Selling and administrative expenses -23.50%9.86M -42.25%10.5M -36.93%11.56M 4.53%59.54M -31.55%10.13M -11.52%12.89M 22.86%18.19M 43.39%18.33M 54.42%56.96M 38.70%14.81M
-General and administrative expense -23.50%9.86M -42.25%10.5M -36.93%11.56M 4.53%59.54M -31.55%10.13M -11.52%12.89M 22.86%18.19M 43.39%18.33M 54.42%56.96M 38.70%14.81M
Research and development costs -51.51%14.8M -64.78%17.25M -60.47%18.69M -14.49%148.27M -52.97%21.5M -39.71%30.53M 18.77%48.97M 32.03%47.28M 31.34%173.39M 22.32%45.71M
Operating profit 66.22%-12.07M 54.95%-25.46M 63.67%-21M 16.10%-170.96M 54.33%-20.93M 40.09%-35.73M -9.18%-56.5M -24.16%-57.8M -20.67%-203.77M 4.59%-45.83M
Net non-operating interest income expense -56.85%986K -45.90%1.19M 3.48%1.7M 1,897.75%8M 108.76%1.88M 1,428.49%2.29M 567.80%2.19M 332.01%1.64M 62.98%-445K 194.75%902K
Non-operating interest income -40.28%1.97M -32.59%2.17M 2.90%2.7M 318.77%12.07M 57.07%2.93M 366.38%3.3M 1,006.19%3.22M 14,461.11%2.62M 4,335.38%2.88M 6,334.48%1.87M
Non-operating interest expense -3.05%986K -4.10%983K 1.93%1M 22.39%4.07M 8.71%1.05M 15.57%1.02M 34.87%1.03M 35.77%983K 162.67%3.33M -1.73%964K
Other net income (expense) -8.71M -499K -8.21M
Special income (charges) --0 ---- ---- ---8.71M ---499K ---8.21M ---- ---- --0 --0
-Less:Restructuring and merger&acquisition --0 ---- ---- --8.71M --499K --8.21M ---- ---- --0 --0
Income before tax 73.39%-11.08M 55.31%-24.27M 65.63%-19.31M 15.94%-171.67M 56.50%-19.54M 30.35%-41.66M -4.00%-54.31M -18.84%-56.16M -20.08%-204.21M 8.29%-44.92M
Income tax 418K 0
Net income 72.39%-11.5M 55.31%-24.27M 65.63%-19.31M 15.94%-171.67M 56.50%-19.54M 30.35%-41.66M -4.00%-54.31M -18.84%-56.16M -20.08%-204.21M 8.29%-44.92M
Net income continuous Operations 72.39%-11.5M 55.31%-24.27M 65.63%-19.31M 15.94%-171.67M 56.50%-19.54M 30.35%-41.66M -4.00%-54.31M -18.84%-56.16M -20.08%-204.21M 8.29%-44.92M
Minority interest income
Net income attributable to the parent company 72.39%-11.5M 55.31%-24.27M 65.63%-19.31M 15.94%-171.67M 56.50%-19.54M 30.35%-41.66M -4.00%-54.31M -18.84%-56.16M -20.08%-204.21M 8.29%-44.92M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 72.39%-11.5M 55.31%-24.27M 65.63%-19.31M 15.94%-171.67M 56.50%-19.54M 30.35%-41.66M -4.00%-54.31M -18.84%-56.16M -20.08%-204.21M 8.29%-44.92M
Basic earnings per share 74.29%-0.09 57.45%-0.2 69.23%-0.16 32.11%-1.48 63.64%-0.16 42.62%-0.35 14.55%-0.47 11.86%-0.52 9.54%-2.18 35.29%-0.44
Diluted earnings per share 74.29%-0.09 57.45%-0.2 69.23%-0.16 32.11%-1.48 63.64%-0.16 42.62%-0.35 14.55%-0.47 11.86%-0.52 9.54%-2.18 35.29%-0.44
Dividend per share
Currency Unit USD USD USD USD USD USD USD USD USD USD
Accounting Standards US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP
Audit Opinions -- -- -- Unqualified Opinion -- -- -- -- -- --

Trending Stocks

U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now